Skip to main content

Advertisement

Log in

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background

In 2003, for the first time, US breast cancer incidence rates have fallen. Experts argue whether this is due to the reduced uptake of screening mammography or to lower use of Hormone Replacement Therapy (HRT). This study aims to disentangle the respective impact of screening and HRT on age-incidence rates and histology of breast cancer, by comparing two populations with comparably high levels of screening mammography, but with different prevalence of HRT.

Methods

We included all invasive breast cancers recorded at the Geneva cancer registry (n = 4,909) and the Netherlands Cancer Registry (n = 152,428) between 1989–2003. We compared age-specific incidence rates and trends in histological subtyping between the two populations.

Results

Between 1989–1991, incidence rates increased with age in both populations. In 2001–2003, women aged 60–64 years showed highest incidence rates in Geneva, while in the Netherlands incidence rates continued to increase with age. The annual increase in ductal cancer incidence was similar in the Netherlands (2.3%) and Geneva (2.5%), but the annual increase in lobular cancer was sharper in Geneva (10%) than in the Netherlands (5%).

Conclusion

The sharp differences in age distribution and histological subtyping of breast cancer between two European populations are not attributable to screening, since both populations have a high uptake of mammography screening. Since the prevalence of HRT use is very high in Geneva and rather low in the Netherlands, HRT may explain these discrepancies. However, other etiological factors and differences in histological assessment may also have played a role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ravdin PA, Cronin KA, Howlander N et al (2006) A sharp decrease in breast cancer incidence in the United States in 2003. Breast Cancer Res Treatm 100:S6–S7

    Google Scholar 

  2. Gøtzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable? Lancet 355:129–134

    Article  PubMed  Google Scholar 

  3. Olsen O, Gøtzsche PC (2001) Systematic review of screening for breast cancer with mammography. The Lancet Publishing Group, London, UK

    Google Scholar 

  4. Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333

    Article  Google Scholar 

  5. Beral V, Million Women Study Collaborators 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427

    Article  PubMed  CAS  Google Scholar 

  6. Jonsson H, Johansson R, Lenner P (2005) Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842–847

    Article  PubMed  CAS  Google Scholar 

  7. Zahl PH, Strand BH, Maehlen J (2004) Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328:921–924

    Article  PubMed  Google Scholar 

  8. Otto SJ, Fracheboud J, Looman CW et al (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361:1411–1417

    Article  PubMed  Google Scholar 

  9. Bouchardy C, Morabia A, Verkooijen HM et al (2006) Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy. BMC Cancer 6:78

    Article  PubMed  Google Scholar 

  10. Prehn A, Clarke C, Topol B et al (2002) Increase in breast cancer incidence in middle-aged women during the 1990s. Ann Epidemiol 12:476–481

    Article  PubMed  Google Scholar 

  11. Fuglede N, Langballe O, Svendsen AL et al (2006) Development in incidence of breast cancer in non-screened danish women, 1973–2002–a population-based study. Int J Cancer 118:2366–2369

    Article  PubMed  CAS  Google Scholar 

  12. Hemminki K, Rawal R, Bermejo JL (2004) Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 22:4652–4653

    Article  PubMed  Google Scholar 

  13. Hemminki K, Bermejo JL (2005) Effects of screening for breast cancer on its age-incidence relationships and familial risk. Int J Cancer 117:145–149

    Article  PubMed  CAS  Google Scholar 

  14. Li CI, Anderson BO, Porter P et al (2000) Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 88:2561–2569

    Article  PubMed  CAS  Google Scholar 

  15. Verkooijen HM, Fioretta G, Vlastos G et al (2003) Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104:778–781

    Article  PubMed  CAS  Google Scholar 

  16. Levi F, Te VC, Randimbison L et al (2003) Increase in lobular breast cancer incidence in Switzerland. Int J Cancer 107:164–165

    Article  PubMed  CAS  Google Scholar 

  17. Li CI, Anderson BO, Daling JR et al. (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424

    Article  PubMed  Google Scholar 

  18. Li CI, Malone KE, Porter PL et al (2003) Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 289:3254–3263

    Article  PubMed  CAS  Google Scholar 

  19. Daling JR, Malone KE, Doody DR et al (2002) Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 95:2455–2464

    Article  PubMed  CAS  Google Scholar 

  20. Tjonneland A, Christensen J, Thomsen BL et al (2004) Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 100:2328–2337

    Article  PubMed  CAS  Google Scholar 

  21. Bouchardy C (1997) Switzerland, Geneva. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) Cancer incidence in five continents. Vol. VII. International Agency for Research on Cancer, Lyon

    Google Scholar 

  22. Chamot E, Charvet AI, Perneger TV (2007) Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland. Eur J Cancer 43:576–584

    Article  PubMed  Google Scholar 

  23. van Duijnhoven FJ, Van Gils CH, Bezemer ID et al (2006) Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997. Maturitas 53:462–475

    Article  PubMed  Google Scholar 

  24. Schaad MA, Bonjour JP, Rizzoli R (2000) Evaluation of hormone replacement therapy use by the sales figures. Maturitas 34:185–191

    Article  PubMed  CAS  Google Scholar 

  25. Morabia A, Costanza MC (2006) Recent reversal of trends in hormone therapy use in a European population. Menopause 13:111–115

    Article  PubMed  Google Scholar 

  26. World Health Organization (1976) ICD-O International classification of diseases for oncology. Geneva

  27. GLIM 4 the statistical system for generalized linear interactive modelling [computer program]. (1993) Oxford University Press, Oxford

  28. Bakken K, Lund E, Eggen AE (2005) The impact of hormone replacement therapy on the incidence of breast cancer in Norway. J Clin Oncol 23:3636–3637

    Article  PubMed  Google Scholar 

  29. Li CI, Weiss NS, Stanford JL et al (2000) Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88:2570–2577

    Article  PubMed  CAS  Google Scholar 

  30. Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 3:467–488

    Article  PubMed  CAS  Google Scholar 

  31. Fechner RE (1975) Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol 6:373–378

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr. H. M. Verkooijen was financially supported by a PROSPER Grant (3233-069350) from the Swiss National Science Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. M. Verkooijen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verkooijen, H.M., Koot, V.C.M., Fioretta, G. et al. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Breast Cancer Res Treat 107, 389–395 (2008). https://doi.org/10.1007/s10549-007-9554-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9554-3

Keywords

Navigation